Empagliflozin in Heart Failure.

Tytuł:: Empagliflozin in Heart Failure.
Autorzy:: Shanmuganathan M; University of Oxford, Oxford, United Kingdom .
Goswami RM; Mayo Clinic, Florida, Jacksonville, FL.
Źródło:: The New England journal of medicine [N Engl J Med] 2021 Jan 28; Vol. 384 (4), pp. 386.
Typ publikacji:: Letter; Comment
Język:: English
Imprint Name(s):: Original Publication: Boston, Massachusetts Medical Society.
MeSH Terms:: Glucosides*/adverse effects
Heart Failure*/drug therapy
Benzhydryl Compounds/adverse effects ; Humans
Substance Nomenclature:: 0 (Benzhydryl Compounds)
0 (Glucosides)
HDC1R2M35U (empagliflozin)
Entry Date(s):: Date Created: 20210127 Date Completed: 20210129 Latest Revision: 20221227
Update Code:: 20240105
DOI:: 10.1056/NEJMc2033669
PMID:: 33503356
: Opinia redakcyjna

Comment on: N Engl J Med. 2020 Oct 8;383(15):1413-1424. (PMID: 32865377)
Comment in: N Engl J Med. 2021 Jan 28;384(4):387-388. (PMID: 33503359)

Informacja